Trial Profile
An Open-label, Randomized, Cross-over, Phase-I Study of Z-944 for the Treatment of Pain
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 30 Jun 2014
Price :
$35
*
At a glance
- Drugs Ulixacaltamide (Primary) ; Ulixacaltamide (Primary)
- Indications Pain
- Focus Adverse reactions; Pharmacokinetics
- Sponsors Zalicus
- 30 Jun 2014 New trial record